We are pleased to share with our friends and colleagues across the globe that: THE NATIONAL PERT CONSORTIUM HAS SUCCESSFULLY ENTERED 4000 UNIQUE PATIENTS INTO THE PERT CONSORTIUM QUALITY DATABASE. This is an incredible milestone and demonstrates a clear commitment from our members to advance the care of patients with Pulmonary Embolism.View
The PERT Consortium invites you to listen to a series of podcasts moderated by past immediate president of PERT Consortium Victor Tapson, MD, and joined by Alex Spyropoulos, MD, as they discuss dedicated DOAC trials that evaluated the treatment of pulmonary embolism including initial treatment, early discharge of low risk PE patients, and extension of treatment to reduce the risk of recurrence.View
The PERT Consortium invites you to listen to a podcast moderated by past immediate president
of PERT, Victor Tapson, MD, and joined by Alex Spyropoulos, MD, and Gregory Piazza, MD, as they
discuss a trial that examined a DOAC for the prophylaxis of VTE in acutely ill medical patients.
Patients: Get the facts about pulmonary embolism, its causes, symptoms, and treatments.
Clinicians: Get the latest updates on pulmonary embolism care and treatment.